Wang Yaru, Chu Juhang, Huang Luyao, Qian Mingping
Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
Eur J Med Res. 2025 Aug 18;30(1):759. doi: 10.1186/s40001-025-02730-0.
The SRY-Box Transcription Factor 9 (SOX9) is a crucial transcription factor that controls the growth, differentiation, and stemness of progenitor cells. According to research, SOX9 protein controls the initiation and progression of tumors by directly participating in tumor initiation, proliferation, migration, and chemotherapy resistance. Although SOX9 overexpression is frequently found in breast cancer, the precise molecular mechanism is yet unknown. This article reviews the structure, function, and new developments of SOX9 in the pathogenesis and treatment of breast cancer, and proposes that targeting SOX9 may improve the therapeutic effect of breast cancer and provide a reference for clinical work.
SRY盒转录因子9(SOX9)是一种关键的转录因子,可控制祖细胞的生长、分化和干性。根据研究,SOX9蛋白通过直接参与肿瘤的起始、增殖、迁移和化疗耐药性来控制肿瘤的发生和发展。虽然SOX9在乳腺癌中经常过度表达,但其确切的分子机制尚不清楚。本文综述了SOX9在乳腺癌发病机制和治疗中的结构、功能及新进展,并提出靶向SOX9可能提高乳腺癌的治疗效果,为临床工作提供参考。